Cardiovascular Outcomes with GLP-1 Receptor Agonists in Patients with Diabetes or Obesity Undergoing Transcatheter Aortic Valve Replacement

By afschroeder • April 23, 2026

Goyal A, Saeed H, Jain H, Hurjkaliani S, Mahalwar G, Jaiswal V, Ricciardi MJ, Kolte D, Fonarow GC, Piazza G, Kapadia S, Qamar A. Cardiovascular Outcomes with GLP-1 Receptor Agonists in Patients with Diabetes or Obesity Undergoing Transcatheter Aortic Valve Replacement. Can J Cardiol. 2026 Apr 20:S0828-282X(26)00358-2. doi: 10.1016/j.cjca.2026.04.003. Epub ahead of print. PMID: 42019817.

Tags: Cardiology/Epi, glp-1 ra, mortality, Outcomes, Publications, Structural, TAVR, transcatheter aortic valve replacement

Characteristics and Outcomes of Over One Million Veterans with Heart Failure Phenotyped Using Artificial Intelligence Approaches: The National DCVA-HF Registry

Zhang S, Raman VK, Shao Y, Patel S, Cheng Y, Workman TE, Sheriff HM, Fonarow GC, Lam PH, Heidenreich PA, Morgan CJ, Moore HJ, Vargas[...]

Cardiology Provider Knowledge and Attitudes Toward Cardiac Gene Therapy: A Multi-Institutional National Survey

Silver E, Punt M, Wang J, Brann A, Khedraki R, Kumar S, Duran A, Greenberg B, Hong KN, Bui QM. Cardiology Provider Knowledge and Attitudes[...]

Pericoronary adipose tissue as a biomarker of coronary atherosclerosis and cardiovascular risk in rheumatoid arthritis

Karpouzas GA, Cosedis Enevoldsen F, Rezaeian P, Masic D, Budoff MJ, Hauge EM, Ormseth SR. Pericoronary adipose tissue as a biomarker of coronary atherosclerosis and[...]